Latest Ratios: P/E Ratio -0.7x · EV/EBITDA N/A · ROE N/A. (2016–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $149M | $98M | $141M | $258M | $410M | $686M | $707M | $253M | $206M | — | — |
| Enterprise Value | $106M | $56M | $-25784272 | $222M | $418M | $713M | $526M | $257M | $96M | — | — |
| P/E Ratio → | -0.68 | — | — | — | — | — | — | — | — | — | — |
| P/S Ratio | 1.45 | 0.96 | 2.28 | 1.68 | 6.05 | 11.09 | 16.55 | 5.91 | 5.37 | — | — |
| P/B Ratio | — | — | 3.17 | 1.72 | 1.89 | 2.72 | 2.13 | 2.58 | 1.57 | — | — |
| P/FCF | — | — | — | — | — | — | — | — | 18.54 | — | — |
| P/OCF | — | — | — | — | 115.52 | — | — | — | 16.26 | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.55 | -0.42 | 1.45 | 6.16 | 11.53 | 12.30 | 6.02 | 2.49 | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | 8.60 | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 92.9% | 92.9% | 88.4% | 95.6% | 87.8% | 84.2% | -80.1% | 100.0% | -41.2% | -0.3% | 27.1% |
| Operating Margin | -102.4% | -102.4% | -384.3% | -58.1% | -190.3% | -159.2% | -166.3% | -129.8% | -96.9% | -37.2% | 2.3% |
| Net Profit Margin | -186.5% | -186.5% | -366.6% | -69.5% | -175.9% | -170.6% | -75.2% | -130.4% | -91.9% | -38.1% | 2.8% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | — | — | -234.2% | -58.2% | -50.8% | -36.1% | -14.9% | -48.6% | -313.4% | — | — |
| ROA | -68.1% | -68.1% | -53.0% | -24.3% | -31.9% | -28.7% | -11.7% | -29.4% | -26.8% | -35.8% | 2.5% |
| ROIC | — | — | — | -39.5% | -38.4% | -34.4% | -42.1% | -67.3% | — | — | — |
| ROCE | -59.3% | -59.3% | -75.4% | -24.9% | -40.3% | -29.7% | -29.1% | -35.8% | -38.1% | -138.1% | 7.1% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | 0.52 | 0.22 | 0.25 | 0.23 | 0.07 | 0.10 | 0.11 | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | 0.17 |
| Net Debt / Equity | — | — | -3.75 | -0.24 | 0.04 | 0.11 | -0.55 | 0.05 | -0.84 | — | — |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | -1.48 |
| Debt / FCF | — | — | — | — | — | — | — | — | -9.94 | — | — |
| Interest Coverage | -4.00 | -4.00 | -6.04 | -3.15 | -33.88 | -32.64 | -7.06 | -11.81 | -23.26 | -27.69 | — |
Net cash position: cash ($58M) exceeds total debt ($16M)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.01 | 2.01 | 2.60 | 4.50 | 5.31 | 5.24 | 12.78 | 3.90 | 5.76 | 0.80 | 0.99 |
| Quick Ratio | 2.01 | 2.01 | 2.60 | 4.50 | 5.31 | 5.24 | 12.78 | 3.90 | 5.76 | 0.80 | 0.99 |
| Cash Ratio | 1.88 | 1.88 | 2.40 | 4.01 | 5.02 | 4.74 | 12.44 | 3.58 | 5.61 | 0.69 | 0.95 |
| Asset Turnover | — | 0.59 | 0.16 | 0.33 | 0.17 | 0.18 | 0.11 | 0.27 | 0.17 | 1.27 | 0.86 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | 14.16 | 50.69 | 85.66 | 38.36 | 73.46 | 47.49 | 53.79 | 23.65 | 11.46 | 3.53 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | 5.4% | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.0% | — | — |
| Shares Outstanding | — | $8M | $8M | $6M | $5M | $5M | $3M | $2M | $2M | $699739 | $44120 |
Includes 30+ ratios · 10 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying STRO stock.
Sutro Biopharma, Inc.'s current P/E ratio is -0.7x. This places it at the 50th percentile of its historical range.
Based on historical data, Sutro Biopharma, Inc. is trading at a P/E of -0.7x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Sutro Biopharma, Inc. has 92.9% gross margin and -102.4% operating margin.